Tag: drug development

Artificial intelligence (AI) stands to drastically reduce both the risks and costs normally associated with the development of new medical products. This could fundamentally reshape pharmaceutical innovation, challenging both the justification for high medicines prices to recoup investment in research and development (R&D) and the market exclusivity systems – including patents and data exclusivity –…